Erythrocytes Nanoparticle Delivery: A Boon for Targeting Tumor

Overview

Journal Adv Pharm Bull

Date 2024 Apr 8

PMID 38585450

Authors

Adnan Rehmatullah Siddique

Geeta Sameer Bhagwat

Affiliations

Soon will be listed here.

Abstract

Although nanoparticles (NPs) have many advantages as drug delivery systems, their poor stability in circulation, premature drug release, and nonspecific uptake in non-target organs have prompted biomimetic approaches to camouflage nano vehicles using natural cell membranes. Among them, which are extensively studied in erythrocytes, are the most abundant circulating blood cells. They are specially used for biomimetic coating on artificial NPs due to their excellent properties of good biocompatibility, biodegradability, non-immunogenicity, and long-term blood circulation. Erythrocyte-mimicking nanoparticles (EM-NPs) are prepared by combining nanoparticle cores with naturally derived erythrocyte (red blood cell or RBC) membranes. Compared with conventional nanosystems, EM-NPs hold the preferable characteristics of prolonged blood circulation time and immune evasion. In this review, the biomimetic platform of erythrocyte membrane-coated NPs is described in various aspects, with particular focus placed on the coating mechanism, preparation methods, characterization method, and recent advances in the biomedical applications of EM-NPs concerning cancer and targeted delivery.

References

Senapati S, Mahanta A, Kumar S, Maiti P . Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 2018; 3:7. PMC: 5854578. DOI: 10.1038/s41392-017-0004-3. View

Wang X, Li H, Liu X, Tian Y, Guo H, Jiang T . Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion. Biomaterials. 2017; 143:130-141. DOI: 10.1016/j.biomaterials.2017.08.004. View

Tan S, Wu T, Zhang D, Zhang Z . Cell or cell membrane-based drug delivery systems. Theranostics. 2015; 5(8):863-81. PMC: 4440443. DOI: 10.7150/thno.11852. View

Wang P, Jiang F, Chen B, Tang H, Zeng X, Cai D . Bioinspired red blood cell membrane-encapsulated biomimetic nanoconstructs for synergistic and efficacious chemo-photothermal therapy. Colloids Surf B Biointerfaces. 2020; 189:110842. DOI: 10.1016/j.colsurfb.2020.110842. View

Shen S, Wang S, Zheng R, Zhu X, Jiang X, Fu D . Magnetic nanoparticle clusters for photothermal therapy with near-infrared irradiation. Biomaterials. 2014; 39:67-74. DOI: 10.1016/j.biomaterials.2014.10.064. View

Ihler G, Tsang H . Hypotonic hemolysis methods for entrapment of agents in resealed erythrocytes. Methods Enzymol. 1987; 149:221-9. DOI: 10.1016/0076-6879(87)49059-9. View

Watts T, Handy R . The haemolytic effect of verapamil on erythrocytes exposed to varying osmolarity. Toxicol In Vitro. 2007; 21(5):835-9. DOI: 10.1016/j.tiv.2007.02.002. View

Chai Z, Hu X, Wei X, Zhan C, Lu L, Jiang K . A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery. J Control Release. 2017; 264:102-111. DOI: 10.1016/j.jconrel.2017.08.027. View

Yang J, Wang F, Lu Y, Qi J, Deng L, Sousa F . Recent advance of erythrocyte-mimicking nanovehicles: From bench to bedside. J Control Release. 2019; 314:81-91. DOI: 10.1016/j.jconrel.2019.10.032. View

10.

Chai Z, Ran D, Lu L, Zhan C, Ruan H, Hu X . Ligand-Modified Cell Membrane Enables the Targeted Delivery of Drug Nanocrystals to Glioma. ACS Nano. 2019; 13(5):5591-5601. DOI: 10.1021/acsnano.9b00661. View

11.

Giordano A, Tommonaro G . Curcumin and Cancer. Nutrients. 2019; 11(10). PMC: 6835707. DOI: 10.3390/nu11102376. View

12.

Hu C, Fang R, Zhang L . Erythrocyte-inspired delivery systems. Adv Healthc Mater. 2012; 1(5):537-47. DOI: 10.1002/adhm.201200138. View

13.

Zhai Z, Xu P, Yao J, Li R, Gong L, Yin Y . Erythrocyte-mimicking paclitaxel nanoparticles for improving biodistributions of hydrophobic drugs to enhance antitumor efficacy. Drug Deliv. 2020; 27(1):387-399. PMC: 7054973. DOI: 10.1080/10717544.2020.1731862. View

14.

Wang H, Zhang C, Zhang Y, Tian R, Cheng G, Pan H . An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles. J Mater Chem B. 2020; 8(14):2876-2886. DOI: 10.1039/d0tb00235f. View

15.

Gao W, Hu C, Fang R, Luk B, Su J, Zhang L . Surface functionalization of gold nanoparticles with red blood cell membranes. Adv Mater. 2013; 25(26):3549-53. PMC: 4138311. DOI: 10.1002/adma.201300638. View

16.

Franco R, Barker R, Novick S, Weiner M, Martelo O . Effect of inositol hexaphosphate on the transient behavior of red cells following a DMSO-induced osmotic pulse. J Cell Physiol. 1986; 129(2):221-9. DOI: 10.1002/jcp.1041290214. View

17.

Zhang Z, Qian H, Huang J, Sha H, Zhang H, Yu L . Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment. Int J Nanomedicine. 2018; 13:4961-4975. PMC: 6124475. DOI: 10.2147/IJN.S170148. View

18.

Raveendran P, Fu J, Wallen S . Completely "green" synthesis and stabilization of metal nanoparticles. J Am Chem Soc. 2003; 125(46):13940-1. DOI: 10.1021/ja029267j. View

19.

Cabel L, Proudhon C, Gortais H, Loirat D, Coussy F, Pierga J . Circulating tumor cells: clinical validity and utility. Int J Clin Oncol. 2017; 22(3):421-430. DOI: 10.1007/s10147-017-1105-2. View

20.

Malhotra S, Dumoga S, Singh N . Red blood cells membrane-derived nanoparticles: Applications and key challenges in their clinical translation. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 14(3):e1776. DOI: 10.1002/wnan.1776. View